Related Experiment Video
Updated: Feb 9, 2026

07:48
Rapid Encapsulation of Reconstituted Cytoskeleton Inside Giant Unilamellar Vesicles
Published on: November 10, 2021
4.9K
Lipid vesicles chaperone an encapsulated RNA aptamer
Ranajay Saha1, Samuel Verbanic2, Irene A Chen3,4
1Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.
Nature Communications
|June 15, 2018
Summary
Encapsulating RNA within fatty acid vesicles enhances its binding affinity and stabilizes its structure. This protocellular organization offers direct benefits to RNA, potentially increasing its fitness and aiding the origin of life.
Area of Science:
- Origin of Life studies
- Biophysics
- Molecular Biology
Background:
- Cellular organization is crucial for life's emergence.
- Early protocells likely involved RNA within lipid vesicles.
- The impact of encapsulation on RNA folding and activity remains unclear.
Purpose of the Study:
- To investigate how confinement within vesicles affects RNA structure and function.
- To understand the role of encapsulation in early cellular evolution.
- To explore the mutualistic relationship between RNA and lipid membranes.
Main Methods:
- Studied the malachite green RNA aptamer confined within fatty acid vesicles.
- Analyzed changes in RNA binding affinity and conformational stability.
- Investigated the role of excluded volume effects due to confinement.
Main Results:
- Vesicle confinement significantly increased the RNA aptamer's binding affinity.
- Encapsulation led to local stabilization of the RNA's bound conformation.
- The vesicle acted as a 'chaperone' for the RNA, suggesting an excluded volume mechanism.
Conclusions:
- Protocellular organization provides direct advantages for RNA activity and stability.
- Encapsulation enhances RNA fitness, supporting the origin of life.
- This highlights a cooperative mechanism between RNA and membranes for mutual benefit.
Related Concept Videos
Molecular Chaperones and Protein Folding
19.9K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
19.9K
Molecular Chaperones and Protein Folding
15.1K
15.1K
What are Lipids?
220.8K
Overview
220.8K
Lipid Digestion
99.6K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
99.6K
Structure of Lipids
99.1K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
99.1K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K

